Chromatographic retention parameters in correlation analysis with in silico biological descriptors of a novel series of N-phenyl-3-methyl succinimide derivatives

Journal of Pharmaceutical and Biomedical Analysis

Volumn 72, Issue , 2013, Pages 65-73

  Perisic Janjic, Nada ^a   Kaliszan, Roman ^b   Milosevic, Natasa ^c   Uscumlic, Gordana ^d   Banjac, Nebojsa ^d  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF NOVI SAD   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

In silico ADMETox determination; QSRR QSAR quantitative structure retention activity relationships; Rational drug design; Reversed phase thin layer chromatography; Succinmides

Indexed keywords

BENZENE DERIVATIVE; HALOGEN; SUCCINIMIDE DERIVATIVE;

ANALYTIC METHOD; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG ABSORPTION; DRUG DESIGN; DRUG DISTRIBUTION; DRUG ELIMINATION; LIPOPHILICITY; PARTITION COEFFICIENT; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVERSED PHASE THIN LAYER CHROMATOGRAPHY; THIN LAYER CHROMATOGRAPHY;

ABSORPTION; ANTICONVULSANTS; CHROMATOGRAPHY, REVERSE-PHASE; CHROMATOGRAPHY, THIN LAYER; COMPUTER SIMULATION; DRUG DESIGN; HALOGENS; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE; SUCCINIMIDES;

EID: 84869015092     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.09.006     Document Type: Article

References (30)

1. Kaminski K., Obniska J. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones. Bioorg. Med. Chem. 2008, 16:4921-4931.
2. Obniska J., Zejc A., Karolak-Wojciechowska J. Synthesis, physicochemical and anticonvulsant properties of new N-pyridyl derivatives of 3-phenyl- and 3,3-diphenyl succinimides. Farmaco 1999, 54:423-429.
3. Perisic Janjic N., Kaliszan R., Wiczling P., Milosevic N., Uscumlic G., Banjac N. Reversed-phase TLC and HPLC tetention data in correlation studies with in silico molecular descriptors and druglikness properties of newly sinthesized anticonvulsant succinimide derivatives. Mol. Pharm. 2011, 8:555-583.
4. Katritzky R.A., Nair K.S., Witeck M.R., Hutchins M.S. Synthesis of 3,3-diarylpyrrolidines from diaryl ketones. ARKIVOC, Issue in Honor of Prof. Gábor Bernáth 2003, 9-18.
5. Hudkins L.R., DeHaven-Hudkins L.D., Doukas P. Design of dual acting anticonvulsant-antimuscarinic succinimide and hydantoin derivatives. Bioorg. Med. Chem. Lett. 1997, 7:979-984.
6. Poupaert H.J., Vandervorst D., Guiot P., Moustafa M.M.M., Dumont P.P. Structure-activity relationships of phenytoin-like anticonvulsant drugs. J. Med. Chem. 1984, 27:76-78.
7. Trisovic N., Valentic N., Uscumlic G. Solvent effects on the structure-property relationship of anticonvulsant hydantoin derivatives: a solvatochromic analysis. Chem. Cent. J. 2011, 5:62-63.
8. Bleicher K.H., Bohm H.J., Muller K., Alanine A.I. Hit and lead generation: beyond high-throughput screening. Nat. Rev. Drug Discov. 2003, 2:369-378.
9. Patsalosa P.N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol. Ther. 2000, 85:77-85.
10. van de Waterbeemd H., Gifford E.E. ADMET in silico modelling: towards prediction paradise?. Nat. Rev. Drug Discov. 2003, 2:192-204.
11. Heberger K. Quantitative structure-(chromatographic) retention relationships. J. Chromatogr. A 2007, 1158:273-305.
12. Kaliszan R. QSRR: quantitative structure-(chromatographic) retention relationships. Chem. Rev. 2007, 107:3212-3246.
13. Nasal A., Siluk D., Kaliszan R. Chromatographic retention parameters in medicinal chemistry and molecular pharmacology. Curr. Med. Chem. 2003, 10:381-426.
14. Perisic -Janjic N.U., Djakovic-Sekulic T.L., Stojanovic Z.S., Penov-Gasi M.K. HPTLC chromatography of androstene derivates. Application of normal phase thin-layer chromatographic retention data in QSAR studies. Steroids 2005, 70:137-144.
15. Banjac N.R., Trisovic N.P., Valentic N.V., Uscumlic G.S., Petrovic S.D. Succinimides: synthesis, properties and anticonvulsant activity. Chem. Ind. 2011, 65:439-453.
16. Soczewiński E. Mechanistic molecular model of liquid-solid chromatography retention-eluent composition relationship. J. Chromatogr. A 2002, 965:109-116.
17. PeriŠić-Janjić N., Djaković-Sekulić T., Stojanović S., Penov-Gaši K. Evaluation of the lipophilicity of some dehydroepiandrostene derivates using RP-18 HPTLC chromatography. Chromatographia 2004, 60:201-205.
18. Winkler D.A. The role of quantitative structure activity relationship (QSAR) in biomolecular discovery. Brief. Bioinform. 2002, 3:73-86.
19. http://146.107.217.178/lab/alogps/start.html.
20. http://www.acdlabs.com/resources/freeware/chemsketch/logp/.
21. Komsta Ł., Skibiński R., Berecka A., Gumieniczek A., Radkiewicz B., Radoń M. Revisiting thin-layer chromatography as a lipophilicity determination tool - a comparative study on several techniques with a model solute set. J. Pharm. Biomed. Anal. 2010, 53:911-918.
22. Cserháti T. Lipophilicity determination of some monoamine oxidase inhibitors: the effect of methanol and ammonium chloride. J. Liq. Chromatogr. 1993, 16:1805-1817.
23. Valkó K.K. Measurements of physical properties for drug design in industry. Separation Methods in Drug Synthesis and Purification 2000, 535-583. Elsevier, Amsterdam. K. Valkó (Ed.).
24. Lipinski A., Lombardo F., Dominy B., Feeney P. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46:3-26.
25. Linnankoski J., Ranta V.P., Yliperttula M., Urtti A. Passive oral drug absorption can be predicted more reliably by experimental than computational models - fact or myth. Eur. J. Pharm. Sci. 2008, 34:129-139.
26. Ghafourian T., Barzegar-Jalali M., Dastmalchi S., Khavari-Khorasani T., Hakimiha N., Nokhodchi A. QSPR models for the prediction of apparent volume of distribution. Int. J. Pharm. 2006, 319:82-97.
27. Stepensky D. Use of unbound volumes of drug distribution in pharmacokinetic calculations. Eur. J. Pharm. Sci. 2011, 42:91-98.
28. Modaa T.L., Montanarib C., Andricopuloa D. In Silico Prediction of Human Plasma Protein Binding Using Hologram QSAR. QSAR Lett. Drug Des. Discov. 2007, 4:502-509.
29. Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehocuk M.P., Fenhart L. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 2007, 6:1-13.
30. Hansch C., Björkroth J.P., Leo A. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 1987, 76:663-687.